Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Tamoxifen
(15067214 | 10540-29-1)
CAS: | 10540-29-1 |
---|---|
Formule moléculaire: | C26H29NO |
Masse moléculaire: | 371.51 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
15067214-100mg | 100mg | £54.00 | |
15067214-1g | 1g | £155.40 | |
Commande en vrac |
15067214-100mg | 100mg | €75.60 | |
15067214-1g | 1g | €217.60 | |
Commande en vrac |
15067214-100mg | 100mg | $81.00 | |
15067214-1g | 1g | $233.10 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 15067214 | ||||
Product Name | Tamoxifen | ||||
Categories | Organics Research Organics & Inorganics | ||||
CAS | 10540-29-1 | ||||
Molecular Formula | C26H29NO | ||||
Molecular Weight | 371.51 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 29221600 |
Spécifications du produit
Melting Point | 97.0 - 99.0 deg C | ||||
Heavy metals | 0.01% Max | ||||
Loss on Drying | 0.5% Max | ||||
Assay (HPLC) | 99.0% Min | ||||
Iron Content | 0.01% Max | ||||
Appearance | White/ off white powder |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|